Coronary Artery Vasospasm Workup
- Author: Stanley S Wang, MD, JD, MPH; Chief Editor: Eric H Yang, MD more...
Evaluation of the standard hematology, serum chemistry, and lipid profiles is appropriate for excluding anemia, infection, primary platelet disorders, renal failure, hyperglycemia, electrolyte abnormalities, and dyslipidemia. Serial measurement of cardiac enzyme and troponin levels should be performed to assess for evidence of ischemia.
Magnesium levels may be checked; magnesium deficiency can heighten sensitivity to acetylcholine- and hyperventilation-induced spasm. Magnesium supplementation may be a potentially useful therapy.
Perfusion Imaging and Echocardiography
Myocardial perfusion imaging may be helpful in ruling out obstructive atherosclerotic disease between episodes of coronary artery vasospasm. During episodes, myocardial perfusion imaging may help identify and quantify ischemia and localize it to the culprit artery.
Standard transthoracic echocardiography should be considered to evaluate for stigmata of other causes of nonexertional chest pain (eg, pericarditis or abnormalities of the aorta). Preliminary data suggest a potential role for hyperventilation and cold-pressor stress echocardiography as a noninvasive means for detecting coronary artery vasospasm, though this method may not be as sensitive as using intracoronary acetylcholine as the provocative agent.
Electrocardiography and Monitoring
Transient ST-segment elevation on electrocardiography (ECG) is a characteristic finding in patients with variant angina, but it may only be present during symptomatic episodes and typically resolves completely within minutes. However, in more severe cases, ST elevation may be followed by T-wave inversions for hours to days. During recovery, U-wave inversions may be present, particularly in lead V5.
Many episodes of coronary artery vasospasm are brief and may be asymptomatic; however, ST-segment changes may be detected by ambulatory electrocardiography, which may allow for more accurate characterization of the frequency and duration of attacks.
Severe vasospastic angina may result in heart block or potentially fatal ventricular arrhythmias. Inpatient telemetry monitoring serves an important role in acutely ill patients. In outpatients, Holter monitoring may facilitate detection of nonsustained arrhythmias.
Coronary angiography may reveal focal spasm of a coronary artery; when coupled with typical symptoms, ECG changes, and even ventricular dysfunction, this spasm may be pathognomonic for the condition.
Most patients with variant angina and documented coronary artery vasospasm have some angiographic evidence of atherosclerotic coronary artery disease (CAD), which is typically mild. Focal spasm more commonly occurs within 1 cm of an angiographically apparent obstruction. If minimal or no angiographic evidence of CAD is found in a patient who has recently had angina at rest with transient ST-segment elevation, variant angina is the more likely diagnosis, and further testing is unnecessary.
The angiographic demonstration of a myocardial bridge may have prognostic implications as well. Not only are myocardial bridges associated with a higher likelihood of more severe coronary artery vasospasm in response to an intracoronary acetylcholine challenge, but a 2012 study suggested that these patients may have greater related morbidity and mortality.
Provocative testing is infrequently used in clinical practice but may facilitate identification of patients with coronary artery vasospasm.
The most commonly used provocative agent is ergonovine maleate, an ergot alkaloid that stimulates both alpha-adrenergic and serotonergic receptors, exerting a direct constrictive effect on vascular smooth muscle. Normal coronary arteries respond to ergonovine maleate with a mild diffuse spasm, whereas abnormal arteries may respond with an intense focal spasm. Acetylcholine and hyperventilation have also been used to provoke spasm.
Intravenous (IV) administration of incremental doses of methylergonovine, starting at 0.05 mg and increasing to a maximum of 0.40 mg, is both sensitive and specific, and there is an inverse relation between the dose required to provoke spasm in the laboratory and the frequency of spontaneous episodes experienced by the patient.
To ensure a valid test, nitrates and calcium antagonists must be withdrawn for at least 48 hours before testing. The intracoronary route of administering methylergonovine is preferable for provocation of spasm and affords the opportunity to evaluate the left and right coronary circulations separately. Small dosing increments (ie, 5-10 µg) are used, with the total dose not to exceed 50 µg.
Intracoronary nitrates should be readily available. Complication rates during provocative testing are relatively low with either ergonovine or acetylcholine, provided that intracoronary nitrates are on hand for use to relieve induced spasms. A 2012 study showed that use of beta blockers during the intracoronary acetylcholine provocation test in patients with vasospastic angina is not associated with a worsening of clinical and angiographic parameters.
A 2015 study suggests that left-ventricular end diastolic pressure (LVEDP) may be effective in identifying myocardial ischemia during ergonovine provocation testing.
Absolute contraindications to provocative testing with methylergonovine include the following:
Severe left ventricular dysfunction
Moderate-to-severe aortic stenosis
High-grade left main coronary stenosis
Significant stenoses in epicardial coronary vessels
Relative contraindications include the following:
Uncontrolled or unstable angina
Uncontrolled ventricular arrhythmia
Advanced coronary disease
Prinzmetal M, Kennamer R, Merliss R. A variant form of angina pectoris. Am J Med. 1959. 27:375-388.
Maseri A, Severi S, Nes MD, et al. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978 Dec. 42(6):1019-35. [Medline].
Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm. Circulation. 1979 May. 59(5):938-48. [Medline].
Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol. 2008 Feb. 51(1):2-17. [Medline].
Ajani AE, Yan BP. The mystery of coronary artery spasm. Heart Lung Circ. 2007 Feb. 16(1):10-5. [Medline].
Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J. 1976 Feb. 91(2):148-55. [Medline].
Yasue H, Horio Y, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation. 1986 Nov. 74(5):955-63. [Medline].
Kaneda H, Taguchi J, Kuwada Y, et al. Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. Circ J. 2006 Apr. 70(4):409-13. [Medline].
Nishijima T, Nakayama M, Yoshimura M, et al. The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm. Pharmacogenet Genomics. 2007 Aug. 17(8):581-7. [Medline].
Egashira K, Katsuda Y, Mohri M, et al. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol. 1996 May. 27(6):1444-9. [Medline].
Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K. Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm. Circulation. 2002 Apr 30. 105(17):2024-9. [Medline].
Stern S, Bayes de Luna A. Coronary artery spasm: a 2009 update. Circulation. 2009 May 12. 119(18):2531-4. [Medline].
Adlam D, Azeem T, Ali T, Gershlick A. Is there a role for provocation testing to diagnose coronary artery spasm?. Int J Cardiol. 2005 Jun 22. 102(1):1-7. [Medline].
Harding MB, Leithe ME, Mark DB, et al. Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. J Am Coll Cardiol. 1992 Jul. 20(1):107-11. [Medline].
Bertrand ME, LaBlanche JM, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982 Jun. 65(7):1299-306. [Medline].
Sueda S, Kohno H, Fukuda H, et al. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology. 2004 Jul-Aug. 55(4):403-11. [Medline].
Sueda S, Kohno H, Oshita A, et al. Coronary abnormal response has increased in Japanese patients: Analysis of 17 years' spasm provocation tests in 2093 cases. J Cardiol. 2010 May. 55(3):354-361. [Medline].
Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J. 1996 Jul. 17(7):1015-21. [Medline].
Mayer S, Hillis LD. Prinzmetal's variant angina. Clin Cardiol. 1998 Apr. 21(4):243-6. [Medline].
Selzer A, Langston M, Ruggeroli C, Cohn K. Clinical syndrome of variant angina with normal coronary arteriogram. N Engl J Med. 1976 Dec 9. 295(24):1343-7. [Medline].
Rha SW, Park JY, Ryu SK, et al. TCT-437 The impact of gender difference on angiographic characteristics during intracoronary acetylcholine provocation test in Korean patients. J Am Coll Cardiol. 2012 Oct 23. 60(17 Supp B):B124.
Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation. 2000 Mar 14. 101(10):1102-8. [Medline].
Bott-Silverman C, Heupler FA Jr. Natural history of pure coronary artery spasm in patients treated medically. J Am Coll Cardiol. 1983 Aug. 2(2):200-5. [Medline].
Mishra PK. Variations in presentation and various options in management of variant angina. Eur J Cardiothorac Surg. 2006 May. 29(5):748-59. [Medline].
Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988 Jul. 78(1):1-9. [Medline].
Onaka H, Hirota Y, Shimada S, et al. Prognostic significance of the pattern of multivessel spasm in patients with variant angina. Jpn Circ J. 1999 Jul. 63(7):509-13. [Medline].
Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U. 3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. J Am Coll Cardiol. 2011 Jan 11. 57(2):147-52. [Medline].
Takagi Y, Takahashi J, Yasuda S, et al. Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association. J Am Coll Cardiol. 2013 Sep 24. 62(13):1144-53. [Medline].
Kobayashi N, Hata N, Shimura T, et al. Characteristics of patients with cardiac arrest caused by coronary vasospasm. Circ J. 2013. 77(3):673-8. [Medline].
Hendriks ML, Allaart CP, Bronzwaer JG, Res JJ, de Cock CC. Recurrent ventricular fibrillation caused by coronary artery spasm leading to implantable cardioverter defibrillator implantation. Europace. 2008 Dec. 10(12):1456-7. [Medline].
Figueras J, Cortadellas J, Gil CP, Domingo E, Soler JS. Comparison of clinical and angiographic features and longterm follow-up events between patients with variant angina and patients with ST elevation myocardial infarction. Int J Cardiol. 2006 Aug 10. 111(2):256-62. [Medline].
Previtali M, Klersy C, Salerno JA, et al. Ventricular tachyarrhythmias in Prinzmetal's variant angina: clinical significance and relation to the degree and time course of S-T segment elevation. Am J Cardiol. 1983 Jul. 52(1):19-25. [Medline].
Rosamond W. Are migraine and coronary heart disease associated? An epidemiologic review. Headache. 2004 May. 44 Suppl 1:S5-12. [Medline].
Hirano Y, Uehara H, Nakamura H, et al. Diagnosis of vasospastic angina: comparison of hyperventilation and cold-pressor stress echocardiography, hyperventilation and cold-pressor stress coronary angiography, and coronary angiography with intracoronary injection of acetylcholine. Int J Cardiol. 2007 Apr 4. 116(3):331-7. [Medline].
Miwa K, Kambara H, Kawai C, Murakami T. Two electrocardiographic patterns with or without transient T-wave inversion during recovery periods of variant anginal attacks. Jpn Circ J. 1983 Dec. 47(12):1415-22. [Medline].
Im SI, Rha SW, Choi BG, et al. TCT-436 Association of myocardial bridge and acetylcholine dose response in patients with vasospastic angina. J Am Coll Cardiol. 2012 Oct. 60(17 Supp B):B124.
Sueda S, Kohno H, Fukuda H, et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis. 2004 Dec. 15(8):491-7. [Medline].
Im SI, Choi BG, Choi SY, et al. TCT-433 Impact of beta-blocker on angiographic and clinical parameters during intracoronary acetylcholine provocation test. J Am Coll Cardiol. 2012. 60(17 Supp B):B123.
Jang HJ, Kim TH, Kwon SW, et al. Left ventricular end diastolic pressure for detection of intracoronary ergonovine-induced myocardial ischemia. Herz. 2015 Nov 6. [Medline].
Piao ZH, Jeong MH, Li Y, et al, for the Other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Benefit of statin therapy in patients with coronary spasm-induced acute myocardial infarction. J Cardiol. 2015 Nov 13. [Medline].
Taylor SH. Usefulness of amlodipine for angina pectoris. Am J Cardiol. 1994 Jan 27. 73(3):28A-33A. [Medline].
Krishnan U, Win W, Fisher M. First report of the successful use of bosentan in refractory vasospastic angina. Cardiology. 2010. 116(1):26-8. [Medline].
Khitri A, Jayasuriya S, Habibzadeh MR, Movahed MR. Coronary stenting in patients with medically resistant vasospasm. Rev Cardiovasc Med. 2010 Fall. 11(4):264-70. [Medline].
Bertrand ME, Lablanche JM, Rousseau MF, Warembourg HH Jr, Stankowtak C, Soots G. Surgical treatment of variant angina: use of plexectomy with aortocoronary bypass. Circulation. 1980 May. 61(5):877-82. [Medline].